
Top Stories 
Published On July 23, 2010
POLICY
Why Recertify?
Does the recertification process prove physicians’ expertise or just waste their time?
For physicians an important measure of competence is board certification—a way to demonstrate knowledge in a specialty, subspecialty or both by passing a rigorous test of expertise. Though only state licensing exams are legally required for practicing medicine in the United States, board certification has come to be expected by some medical groups and hospitals, health plan payers and knowledgeable consumers. About 85% of U.S. physicians are certified by one of the two dozen American Board of Medical Specialties member boards, which cover 145 medical specialties.
Though some specialties, such as general surgery, have long required recertification, until recently most board certifications were good for life. Since 2006, however, physicians have been subject to new ABMS rules: They must pass a written exam every six to 10 years, and they’re asked to complete “modules” every one to five years that may include analyzing medical records to see whether patients received care that was up to the latest standards and assessing communication skills with patients. Only doctors who received board certification before 1990 are exempt from recertification.
It’s no secret that physicians find the recertification process time-consuming and costly, with test fees of $3,000 or more. And in a recent online poll by the New England Journal of Medicine—which asked doctors to consider the hypothetical example of a 55-year-old physician, board certified in endocrinology and in practice for 24 years—63% of 2,512 physicians said the specialist shouldn’t volunteer for recertification testing.
“Recertification is a good idea in theory,” says Lee Goldman, a cardiologist and dean of health sciences at Columbia University, who co-authored an article criticizing recertification that accompanied the NEJM poll. But passing a written exam doesn’t necessarily make for a better mid-career doctor, argues Goldman, particularly if the required knowledge isn’t useful in day-to-day practice. “It would be ideal to ask doctors to identify the most common problems and diagnoses they encounter in their practices,” he says. ““For some doctors, much of the exam may be irrelevant.”
ABMS president Kevin Weiss counters that member boards have created recertification programs that will build physicians’ knowledge base and improve their skills. “The intent is to derive a higher-quality workforce,” says Weiss. “We’re finding that physicians aren’t concerned about the time recertification takes if it adds value to their experience.“
Recertification is part of a broader push toward accountability that also includes employers and health plan payers assessing physician performance. Doctors who choose to go through the process may collect additional reimbursement, and the new health care law mandates bonuses, starting next year, for physicians who are recertified and participate in Medicare pay-for-performance programs.
Though encouraged that some specialties are supplementing exams with elements that may more directly relate to physician practices, Goldman remains skeptical. “A secure test of recall may not be nearly as relevant as knowing how to use the myriad modern sources of information,” he notes.
Goldman, who became board certified in the 1970s, says he has no plans to recertify. Many of the 250,000 other physicians grandfathered in with lifetime certificates, and the 150,000 or so physicians who have never earned board certification, are likely to feel the same way.
Dispatches

What Makes a Kid Clumsy? More research into coordination disorders shows why some children are more prone to trip, fumble and spill the milk.

Eyes in the Sky Satellite data can be used to assess the health impact of dust storms and the spread of mosquito-borne diseases. Additional applications could be on the horizon.

Could This One Change Help Curb the Opioid Crisis? To prescribe an effective bridge to addiction treatment, emergency physicians must get special training and receive a waiver. Making that process easier—or eliminating the requirement altogether—could make a big impact.

One Thing Leads to the Next Robert Lefkowitz is best known for revealing the mechanism behind hundreds of drugs in use today. But he thinks of himself as a storyteller first and has a new book out to make his case.

Podcast: The Research Year That Was Medical research labs have faced a difficult stretch of closed buildings and competing priorities. Yet they have also produced milestone discoveries—and not only on COVID-19.

The Shape of Us Two milestone discoveries in protein modeling promise to change the fundamentals of drug discovery.

Universal Flu Vaccines Move Forward In the shadow of coronavirus vaccine development, another vaccine was making solid progress.

Top Stories 

The Neuroscience of Giving Up
Why do some people react poorly, even catastrophically, in emergency situations?